Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and blood ...

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Scientists found that obesity may exist in 11 biological forms, each linked to different genes and body functions.

The prevalence of long COVID-typical symptom clusters was relatively high among a cohort of adults 2 years after initial COVID-19 infection.

In the first part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, describes the US payer ecosystem’s ...

Findings reveal that the health of children in the U.S. has deteriorated across nearly every major health indicator over the ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis published in BMC Medicine.

Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired hypothalamic obesity.

Get a closer look at five symptoms that could be warning signs of cancer.